Now accepting Telehealth appointments. Schedule a virtual visit.

TMS for Parkinson's Disease

Parkinson's disease is a neurodegenerative disease that affects more than 6 millions individuals. Patients with Parkinson's disease are presented with resting tremors, rigidity, bradykinesia, postural instability, depression, sleep disorder, and cognitive deficits. Fortunately, research has been done with transcranial magnetic stimulation (TMS) to help with the burdens of Parkinson's disease.

Non-pharmacological interventions are now being considered as a significant part of treatments for Parkinson's disease which include rehabilitation training and neuromodulation techniques, including TMS. This is exciting news as the primary protocol for alleviating symptoms of PD is a drug called Levodopa. The results from a meta-study analysis indicated that high-freqency stimulation over bilateral M1 and DLPFC has the most effective benefits on the motor symptoms in parkinson's disease. The M1 region of the brain is responsible for controlling voluntary movement while the DLPFC coordinates higher level cognitive processing and communicates with the M1. 

TMS uses a non-invasive neuromodulation technique aimed at stimulating specific brain regions. This consists of two magnetic coils placed on the head to create a magnetic field to stimulate neuronal activity in the brain. In Parkinson's there is a reduction in dopamine in the striatum, however targetting the M1 and the DLPFC influences the release of dopamine to the striatum thereby potentially helping the motor symptoms associated with Parkinson's disease. 

To read more about the academic journal, click here.

You Might Also Enjoy...

988 - A Mental Health Lifeline

988 is a mental health crisis line. A shortened version of the 1-800-273-TALK (8255), this line is specifically used for any mental health related emergency.

TMS and Its Wide Application

FDA's approval of TMS for Major Depressive Disorder (MDD) in 2008 has sparked researchers to take a dive and explore further implications of TMS for other drug-resistant psychiatric disorders.

SAINT Protocol Now Cleared by the FDA

Read about how the Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for the treatment of major depressive disorder is now cleared by the US Food & Drug Administration (FDA).